Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy

被引：0
|
作者：
Hazim, A. [1 ]
Xiao, A. [1 ]
Singh, A. [1 ]
Chung, K. [2 ]
dos Santos, P. A. Reck [2 ]
D'Cunha, J. [2 ]
Shanshal, M. [1 ]
Dimou, A. [1 ]
Parikh, K. [1 ]
Lou, Y. [3 ]
Manochakian, R. [3 ]
Leventakos, K. [1 ]
Molina, J. [1 ]
Mansfield, A. [1 ]
Ernani, V. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
chemoimmunotherapy; neoadjuvant; non small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07C.16
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [1] A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer
    Zhang, Baihua
    Xiao, Haifan
    Pu, Xingxiang
    Zhou, Chunhua
    Yang, Desong
    Li, Xu
    Wang, Wenxiang
    Xiao, Qin
    CANCER MEDICINE, 2023, 12 (01): : 274 - 286
  • [2] Neoadjuvant therapy in early-stage non-small cell lung cancer: A real-world analysis
    Ay, Leyla
    Steiner, Daniel
    Fabikan, Hannah
    Illini, Oliver
    Krenbek, Dagmar
    Klikovits, Thomas
    Benej, Michal
    Kirchbacher, Klaus
    Watzka, Stefan
    Valipour, Arschang
    Hochmair, Maximilian
    LUNG CANCER, 2024, 198
  • [3] Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
    Wu, Junqi
    Hou, Likun
    Zhao, Yue
    Yu, Xin
    Xu, Long
    Ning, Ye
    Deng, Jiajun
    Sun, Ke
    Zhang, Jie
    Wu, Chunyan
    Zhu, Yuming
    Zhao, Deping
    She, Yunlang
    Su, Chunxia
    Chen, Chang
    Haoran, E.
    LUNG CANCER, 2022, 165 : 115 - 123
  • [4] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    Current Treatment Options in Oncology, 2021, 22
  • [5] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [6] Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study
    Zhou, Sihao
    Liu, Yi
    Liu, Kejun
    Zhang, Junkai
    Liang, Hanlin
    Wu, Yingmeng
    Ye, Hongyu
    Liang, Yi
    Zhang, Jingjing
    Huang, Weizhao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
    Hu, Yan
    Ren, Si-Ying
    Wang, Ruo-Yao
    Zeng, Chao
    Li, Ji-Na
    Xiao, Peng
    Wu, Fang
    Yu, Feng-Lei
    Liu, Wen-Liang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice
    Huang, Xiaojie
    Pang, Guanchao
    Mao, Zhirong
    Li, Baizhou
    Teng, Zhihua
    Yang, Yan
    Qiu, Zijian
    Chen, Xiuxiu
    Wang, Pingli
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05)
  • [9] Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer
    Shen, Jie
    Gu, Linping
    Qi, Yuwen
    Yao, Yaxian
    Lu, Shun
    Chen, Zhiwei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis
    Zhang, Baihua
    Guo, Xiaotong
    Jia, Ran
    Wang, Zhan
    Wu, Jie
    Chen, Xiaoyan
    Li, Jigang
    Yang, Desong
    Li, Xu
    Wang, Wenxiang
    Xiao, Qin
    FRONTIERS IN ONCOLOGY, 2023, 13
12345